SARS-CoV-2 Pseudovirus Neutralization Assay
Corresponding Organization :
Other organizations : University of Miyazaki, Hiroshima University, Hokkaido University, Tokyo University of Science, Kumamoto University, The University of Tokyo, National Institute of Infectious Diseases, Kyoto University, Tokyo Metropolitan Institute of Public Health, Tokai University, University of Wisconsin–Madison, Hokkaido University Hospital, National Center for Global Health and Medicine, Japan Science and Technology Agency
Protocol cited in 9 other protocols
Variable analysis
- SARS-CoV-2 S protein and its derivatives
- Plasmids expressing parental S or its derivatives
- Luciferase activity (luminescent signal) in infected cells
- HEK293T cells (1 × 10^6 cells)
- Amounts of plasmids used for cotransfection (1 μg of psPAX2-IN/HiBiT, 1 μg of pWPI-Luc2, 500 ng of plasmids expressing parental S or its derivatives)
- Cell lines used for infection (HOS-ACE2 cells and HOS-ACE2/TMPRSS2 cells)
- Infection conditions (100 μl of pseudoviruses at four different doses)
- Not specified
- Not specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!